Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-0001, Japan.
Mie University Hospital, 2-174 Edobashi, Tsu, Mie, 514-0001, Japan.
BMC Surg. 2020 Oct 31;20(1):261. doi: 10.1186/s12893-020-00917-2.
Several inflammation-based scores are used to assess the surgical outcomes of hepatocellular carcinoma (HCC). The aim of the present study was to elucidate the prognostic value of the prognostic nutritional index (PNI) in HCC patients who underwent hepatectomy with special attention to preoperative liver functional reserve.
Preoperative demographic and tumor-related factors were analyzed in 189 patients with HCC undergoing initial hepatectomy from August 2005 to May 2016 to identify significant prognostic factors.
Multivariate analysis for overall survival (OS) revealed that female sex (p = 0.005), tumor size (p < 0.001) and PNI (p = 0.001) were independent prognostic factors. Compared to the High PNI group (PNI ≥ 37, n = 172), the Low PNI group (PNI < 37, n = 17) had impaired liver function and significantly poorer OS (13% vs. 67% in 5-year OS, p = 0.001) and recurrence-free survival (RFS) (8 vs. 25 months in median PFS time, p = 0.002). In the subgroup of patients with a preserved liver function of LHL15 ≥ 0.9, PNI was also independent prognostic factor, and OS (21% vs. 70% in 5-year OS, p = 0.008) and RFS (8 vs. 28 months in median PFS time, p = 0.018) were significantly poorer in the Low PNI group than the High PNI group.
PNI was an independent prognostic factor for HCC patients who underwent hepatectomy. Patients with PNI lower than 37 were at high risk for early recurrence and poor patient survival, especially in the patients with preserved liver function of LHL ≥ 0.9.
有几种基于炎症的评分用于评估肝细胞癌(HCC)的手术结果。本研究的目的是阐明在接受肝切除术的 HCC 患者中,预后营养指数(PNI)的预后价值,特别关注术前肝功能储备。
分析了 2005 年 8 月至 2016 年 5 月期间接受初次肝切除术的 189 例 HCC 患者的术前人口统计学和肿瘤相关因素,以确定显著的预后因素。
多变量分析显示,女性(p=0.005)、肿瘤大小(p<0.001)和 PNI(p=0.001)是总生存期(OS)的独立预后因素。与高 PNI 组(PNI≥37,n=172)相比,低 PNI 组(PNI<37,n=17)肝功能受损,OS(5 年 OS 中 13% vs. 67%,p=0.001)和无复发生存率(RFS)(中位 PFS 时间 8 个月 vs. 25 个月,p=0.002)明显更差。在保留肝功能 LHL15≥0.9 的患者亚组中,PNI 也是独立的预后因素,OS(5 年 OS 中 21% vs. 70%,p=0.008)和 RFS(中位 PFS 时间 8 个月 vs. 28 个月,p=0.018)在低 PNI 组明显更差。
PNI 是接受肝切除术的 HCC 患者的独立预后因素。PNI 低于 37 的患者早期复发和患者生存不良的风险较高,尤其是保留肝功能 LHL≥0.9 的患者。